ETSTOTCPharmaceutical PreparationsFiscal year ends March 31
Earth Science Tech, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.09+0.00 (+3.73%)
Close on Oct 19, 2026
- Market cap
- $25.57M
- P/E (TTM)
- 9.8
- Dividend yield
- –
Earth Science Tech, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2026 | FY2025 | % of revenue | YoY |
|---|---|---|---|---|
| Sale of Pharmaceutical Products and Medical Consultations [Member] | $32.91M | $30.03M | 92.2% | +9.6% |
| Shipping and Handling [Member] | $2.49M | $3.09M | 7.0% | -19.6% |
| Other Revenue [Member] | $300.83K | – | 0.8% | – |
By region
From the segment and revenue-disaggregation notes of Earth Science Tech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.